Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Genentech Announces FDA Approval for Venclexta Plus Gazyva for People with CLL

americanpharmaceuticalreviewMay 23, 2019

Tag: Genentech , FDA , approval

PharmaSources Customer Service